IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Astellas Pharma Japan sedol 69

CUSIP: J03393105 | 3 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

Zevin Asset Management LLC17,600
0.0% of portfolio›$228
StyleTurnoverLocationFiled
Zevin Asset Management LLC
17,600$2280.0%GrowthLowBoston, MA2019-02-05